[1. Kwon-Chung KJ. Taxonomy of Fungi Causing Mucormycosis and Entomophthoramycosis (Zygomycosis ) and Nomenclature of the Disease: Molecular Mycologic Perspectives. Clin Infect Dis. 2012;54(Suppl 1):S8-S15. DOI: 10.1093/cid/cir864.10.1093/cid/cir864327623522247451]Search in Google Scholar
[2. Onyango J, Kayima JK, Owen WO. Rhinocerebral mucormycosis: case report. East African J. 2002;79(7):390-3.10.4314/eamj.v79i7.884512638836]Search in Google Scholar
[3. Sahota R, Gambhir R, Anand S, Dixit A. Rhinocerebral Mucormycosis: Report of a Rare Case. Ethiop J Health Sci. 2017;27(1):85-90.10.4314/ejhs.v27i1.11539023228458494]Search in Google Scholar
[4. Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi. 2019;5(1):26. DOI: 10.3390/jof5010026.10.3390/jof5010026646291330901907]Open DOISearch in Google Scholar
[5. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18(3):556–69.10.1128/CMR.18.3.556-569.200516020690119596416020690]Open DOISearch in Google Scholar
[6. Wali U, Balkhair A, Al-Mujaini A. Cerebro-rhino orbital mucormycosis: an update. J Infect Public Health. 2012;5(2):116–26. DOI: 10.1016/j.jiph.2012.01.003. Epub 2012 Mar 27.10.1016/j.jiph.2012.01.003.Epub201227]Open DOISearch in Google Scholar
[7. Alleyne CH Jr, Vishteh AG, Spetzler RF, Detwiler PE. Long-terme survival of a patient with invasive cranial base rhinocerebral mucormycosis treated with combined endovascular, surgical and medical therapies: case report. Neurosurg. 1999;45(6):1461-3; discussion 1463-4.10.1097/00006123-199912000-0003710598714]Search in Google Scholar
[8. Ohtomo K, Ueta T, Nagahara M. Traumatic orbital apex syndrome. Can J Ophthalmol. 2015;50:e7–e8. DOI: 10.1016/j.jcjo.2014.10.012.10.1016/j.jcjo.2014.10.01225677300]Search in Google Scholar
[9. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and Clinical Manifestations of Mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23-34. DOI: 10.1093/cid/cir866.10.1093/cid/cir86622247442]Open DOISearch in Google Scholar
[10. Silvernan CS, Mancuso AA. Periantral soft-tissue infiltration and its relevance to the early detection of invasive fungal sinusitis: CT and MR findings. AJNR Am J Neuroradiol. 1998;19(2):321–5.]Search in Google Scholar
[11. Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. Recent Advances in the Management of Mucormycosis: From Bench to Bedside. Clin Infect Dis. 2009;48(12):1743-51. DOI: 10.1086/599105.10.1086/599105280921619435437]Open DOISearch in Google Scholar
[12. Blyth CC, Gomes L, Sorrell TC, da Cruz M, Sud A, Chen SC. Skull-base osteomyelitis: fungal vs. bacterial infection. Clin Microbiol Infect. 2011;17(2):306-11. DOI: 10.1111/j.1469-0691.2010.03231.x.10.1111/j.1469-0691.2010.03231.x]Open DOISearch in Google Scholar
[13. deShazo RD, O’Brein M, Chapin K, Soto-Aguilar M, Gardner L, Swain R. A new classification and Diagnostic Criteria for Invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg. 1997;123(11):1181-8.10.1001/archotol.1997.01900110031005]Search in Google Scholar
[14. Alobid I, Bernal M, Calvo C, Vilaseca I, Berenguer J, Alos L. Treatment of Rhinocerebral Mucormycosis by Combination of Endoscopic Sinus Debridement and Amphotericin B. Am J Rhinol. 2001;15(5):327-31.10.1177/194589240101500508]Open DOISearch in Google Scholar
[15. Spellberg B., Ibrahim A. Recent Advances in the Treatment of Mucormycosis. Curr Infect Dis Rep. 2010;12(6):423-9. DOI: 10.1007/s11908-010-0129-9.10.1007/s11908-010-0129-9]Open DOISearch in Google Scholar
[16. Katragkou A, Walsh TJ, Roilides E. Why is mucormycosis more difficult to cure than more common mycoses? Clin Microbiol Infect. 2014;20 Suppl 6:74-81. DOI: 10.1111/1469-0691.12466. Epub 2014 Jan 28.10.1111/1469-0691.12466.Epub201428]Open DOISearch in Google Scholar
[17. Adler DE, Milhorat TH, Miller JI. Treatment of rhinocerebral mucormycoosis with i.v., interstitial and cerebrospinal fluid administration of amphotericin B: case report. Neurosurgery. 1998;42(3):644-8; discussion 648-9.10.1097/00006123-199803000-00037]Search in Google Scholar
[18. Ferry AP. Abedi S. Diagnosis and management of rhinoorbitocerebral and mucormycosis (phycomycosis): A report of 16 personally observed cases. Ophthalmology. 1983;90(9):1096-104.10.1016/S0161-6420(83)80052-9]Open DOISearch in Google Scholar
[19. Songu M, Unlu HH, Gunhan K, Ilker SS, Nese N. Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome. Am J Rhinol. 2008;22(1):98-103. DOI: 10.2500/ajr.2008.22.3121.10.2500/ajr.2008.22.3121]Open DOISearch in Google Scholar
[20. Kohn R, Hepler R. Manage ment of Limited Rhino-or bital Mucormycosis without Exenteration. Ophthalmology. 1985;92(10):1440-4.10.1016/S0161-6420(85)33844-7]Search in Google Scholar
[21. Palejwala SK, Zangeneh TT, Goldstein SA, Lemole GM. An aggressive multidisciplinary approach reduces mortality in rhinocerebral mucormycosis. Surg Neurol Int. 2016;7:61. DOI: 10.4103/2151-7806.182964. eCollection 2016.10.4103/2151-7806.182964.eCollection2016]Open DOISearch in Google Scholar
[22. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival Factors in Rhino-Orbital-Cerebral mucormycois. Surv Opththalmol. 1994;39(1):3–22. DOI: 10.1016/S0039-6257(05)80041-4.10.1016/S0039-6257(05)80041-4]Open DOISearch in Google Scholar
[23. Blitzer A, Lawson W, Meyers BR, Biller HF. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope. 1980;90(4):635-48.10.1288/00005537-198004000-000107359982]Search in Google Scholar
[24. Jayalakshmi S, Reddy RG, Borgohain R, Subramanyam C, Panigrahi M, Sundaram C, et al. Predictors of mortality in rhinocerebral mycosis. Neurol India. 2007;55(3):292–7.10.4103/0028-3886.3569217921660]Open DOISearch in Google Scholar